Faculty profile

Michael Law

ResearcherCentre for Health Services and Policy ResearchUniversity of British Columbia

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of British Columbia directory, so their courses and email address may be missing. Find their university profile.

Michael Law

Researcher

Centre for Health Services and Policy Research

Health Sciences

University of British Columbia

Vancouver, British Columbia, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
17 publications in the last five years, latest in 2026.
Senior (last) author on 2 recent papers, a sign of leading a research group.
Principal investigator on 15 research grants (15 CIHR), most recently in 2024.
Supervised 8 trainees who won CIHR awards, most recently in 2023.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Health Services Research Health Policy Prescription Drugs Contraception Access Contraception Policy Health Policy Research Reproductive Population Health Access To Care

Latest papers

All-Cause Mortality in Persons With HIV-HBV Co-Infection Treated for HBV in Rwanda: A Population-Based Cohort Study.
Journal of viral hepatitis · 2026
Hepatitis B Virus Care Cascade in Rwanda: A Population-based Study From 2016-2023.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
Hepatitis B treatment response and factors associated with HBV treatment success: A population-based study in Rwanda.
Hepatology communications · 2026

All 22 publications

Latest funding

The feasibility and costs of pharmacy models supporting rural and remote communities: A simulation study
CIHR · 2025 · Co-investigator
$581,400
Transforming access to medications in rural, remote, and Indigenous communities: Implementing and evaluating virtual pharmacist care and drone delivery services
CIHR · 2025 · Co-investigator
$680,852
Effect of Canada's first universal contraception subsidy on access, pregnancy outcomes, and costs: a population-based controlled interrupted time series study
CIHR · 2024 · Principal investigator
$929,476

All 36 grants and awards

22 publications.

All-Cause Mortality in Persons With HIV-HBV Co-Infection Treated for HBV in Rwanda: A Population-Based Cohort Study.

Makuza JD, Law M, Puyat J, Ramji A, Jeong D, Morrow RL, Adu PA, Nisingizwe MP, Issanov A, Cua G, García HAV, Berabose C, Tuyishime A, Janjua NZ

Journal of viral hepatitis2026

DOI: 10.1111/jvh.70158 PMID: 41724728

Hepatitis B Virus Care Cascade in Rwanda: A Population-based Study From 2016-2023.

Makuza JD, Jeong D, Law M, Puyat JH, Ramji A, Soe P, Morrow RL, Cua G, Velásquez García HA, Nisingizwe MP, Serumondo J, Tuyishime A, Janjua NZ

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America2026

DOI: 10.1093/cid/ciaf393 PMID: 40878054

Hepatitis B treatment response and factors associated with HBV treatment success: A population-based study in Rwanda.

Makuza JD, Law M, Ramji A, Jeong D, Puyat J, Aravindakshan A, Morrow RL, Adu PA, Nisingizwe MP, Cua G, Velásquez García HA, Berabose C, Tuyishime A, Janjua NZ

Hepatology communications2026

DOI: 10.1097/hc9.0000000000000876 PMID: 41564369

Did a Non-Medical Biosimilar Switching Policy Cause an Increase in Non-Biologic/Biosimilar Health Care Resource Utilization or Cost in Patients With Inflammatory Arthritis?

Dang H, Blitz S, Bansback N, Law M, Harrison M

Arthritis care & research2026

DOI: 10.1002/acr.25610 PMID: 41131425

The Longer-Term Impact of Biosimilar Switching Policies in Patients With Inflammatory Bowel Disease in British Columbia, Canada: A Retrospective, Population-Based Study.

Harrison M, Blitz S, Law M, Tadrous M, Gomes T, Clement F, Rosenfeld G, Anis A, Bansback N

Pharmacoepidemiology and drug safety2026

DOI: 10.1002/pds.70395 PMID: 42157439

Prothrombin Complex Concentrate vs Frozen Plasma for Coagulopathic Bleeding in Cardiac Surgery

Karkouti K, Callum JL, Bartoszko J, Tanaka KA, Knaub S, Brar S, Ghadimi K, Rochon A, Mullane D, Couture EJ

Journal of the American Medical Association (JAMA)202563 citations

DOI: 10.1001/jama.2025.3501

The Impact of Longitudinal Substance Use Patterns on the Risk of Opioid Agonist Therapy Discontinuation: A Repeated Measures Latent Class Analysis.

Cui Z, Karamouzian M, Law M, Hayashi K, Milloy MJ, Kerr T

International journal of mental health and addiction2024

DOI: 10.1007/s11469-023-01098-8 PMID: 39722780

Equity of financial protection for health in high-income countries: scoping review protocol.

Xie EC, Ali S, Law M, Allin S, Proaño D, Sander B

BMJ open2024

DOI: 10.1136/bmjopen-2023-081029 PMID: 39578034

The effect of coronary revascularization treatment timing on mortality in patients with stable ischemic heart disease in British Columbia.

Hardiman S, Fradet G, Kuramoto L, Law M, Robinson S, Sobolev B

PloS one2024

DOI: 10.1371/journal.pone.0303222 PMID: 39446787

Health worker protests and the COVID-19 pandemic: an interrupted time-series analysis.

Sharma K, Brophy S, Law M, Sriram V

Bulletin of the World Health Organization2024

DOI: 10.2471/blt.23.290330 PMID: 39219771

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2024

Subject: Prospective PhD student: Health Services Research Dear Professor Law, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "All-Cause Mortality in Persons With HIV-HBV Co-Infection Treated for HBV in Rwanda: A Population-Based Cohort Study." (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Effect of Canada's first universal contraception subsidy on access, pregnancy outcomes, and costs: a population-based controlled interrupted time series study" (2024), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Something wrong or missing on this profile? Suggest a correction

Michael Law

Research

Latest papers

Latest funding

All-Cause Mortality in Persons With HIV-HBV Co-Infection Treated for HBV in Rwanda: A Population-Based Cohort Study.

Hepatitis B Virus Care Cascade in Rwanda: A Population-based Study From 2016-2023.

Hepatitis B treatment response and factors associated with HBV treatment success: A population-based study in Rwanda.

&#x200b;Did a Non-Medical Biosimilar Switching Policy Cause an Increase in Non-Biologic/Biosimilar Health Care Resource Utilization or Cost in Patients With Inflammatory Arthritis?

The Longer-Term Impact of Biosimilar Switching Policies in Patients With Inflammatory Bowel Disease in British Columbia, Canada: A Retrospective, Population-Based Study.

Prothrombin Complex Concentrate vs Frozen Plasma for Coagulopathic Bleeding in Cardiac Surgery

The Impact of Longitudinal Substance Use Patterns on the Risk of Opioid Agonist Therapy Discontinuation: A Repeated Measures Latent Class Analysis.

Equity of financial protection for health in high-income countries: scoping review protocol.

The effect of coronary revascularization treatment timing on mortality in patients with stable ischemic heart disease in British Columbia.

Health worker protests and the COVID-19 pandemic: an interrupted time-series analysis.

Frequent collaborators

Kimberlyn McGrail

Mina Tadrous

Dahn Jeong

Fiona Clement

Mark Harrison

Kanna Hayashi

Guy Fradet

Joseph Puyat

Simon Robinson

Tara Gomes

Keyvan Karkouti

Kanna Hayashi

Justyna Bartoszko

Boris Sobolev

Mohammad Karamouzian

Shehzad Ali

Lusine Abrahamyan

Frederick D'Aragon

Andrew Boozary

Lindsay Hedden

Jeannie Callum

Paul Oh

Veena Sriram

Jessica Spence

Philip Devereaux

Simon Oczkowski

Andre Lamy

Emilie Belley-Cote

Shun Fu Lee

William McIntyre

Matthew Mcfarling

Andreas Laupacis

Braden Manns

Thomas Kerr

Summer Syed

Richard Whitlock

Michelle Zeller

Did a Non-Medical Biosimilar Switching Policy Cause an Increase in Non-Biologic/Biosimilar Health Care Resource Utilization or Cost in Patients With Inflammatory Arthritis?